Back to search

Article

Doxorubicin Drives Chemoresistance in Osteosarcoma by Inducing Adaptive Plasticity and IL-1β/COX-2-mediated Inflammation

2026-08-07

Abstract excerpt

<title>Abstract</title> <p>Osteosarcoma is the most frequent bone malignancy in children and adolescents. Unfortunately, despite advances in treatment, chemoresistance and tumour recurrence remain major challenging obstacles. Increasing evidence suggests that surviving malignant cells can undergo adaptive reprogramming following chemotherapy, attaining cancer stem cell (CSC)-associated characteristics and other c...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
934b9033-af0a-5b92-809e-2f8e06724494
DOI
10.21203/rs.3.rs-10122129/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Doxorubicin Drives Chemoresistance in Osteosarcoma by Inducing Adaptive Plasticity and IL-1β/COX-2-mediated InflammationDOI 10.21203/rs.3.rs-10122129/v1
Select a neighboring publication to make it the new centre.